Urgent warning about contaminated weight loss injections from UK Government
‘Fake fat jab sellers’ warning from health minister who tells the Mirror dodgy weight loss injections can cause…
Lilly’s triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial
In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost an average of 28.7% of…
Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide
Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly’s global supply chain INDIANAPOLIS,…
Lilly’s Kisunla (donanemab) receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer’s disease
Approved for earliest symptomatic stages of disease, demonstrating significant slowing of cognitive and functional decline Only therapy with…
Weight loss jab patients urged to avoid ‘risky’ move after Mounjaro change
A medical expert has warned users of Mounjaro that an increasingly popular way to use the jab could…